Peinado et al. demonstrated how MET oncoprotein enriched in sEVs from melanoma cells altered the tumour microenvironment by promoting a metastatic niche through the activation of downstream mediators of MET signalling through the phosphorylation of S6-kinase and MAPK1 [14]. Here, MET is linked to melanoma.